Skip to main navigation
Accessibility Recite Me
MeiraGTx
  • Company
    • About Us
    • Our Team
    • Board of Directors
    • Scientific Advisory Board
    • Contact Us
  • Our Strategy
    • Scientific Platform
    • Therapeutic Areas
    • Manufacturing
    • Gene Regulation
  • Research & Development
    • Pipeline
    • Clinical Trials
    • Posters & Publications
  • Patients & Families
  • Investors & Media
    • Overview
    • News Releases
    • Events & Presentations
    • Stock Information
    • Corporate Governance
    • Financial Information
    • Investor Resources
  • Join Our Team

Investors & Media

Investors & Media

  • Overview
  • News Releases
  • Events & Presentations
  • Stock Information
  • Corporate Governance
  • Financial Information
  • Investor Resources

Stockholder Tools

  • Print Page
  • RSS Feeds
  • Email Page
  • Email Alerts

SEC Filing Details

Document Details
Form
10-K
Filing Date
Mar 14, 2023
Document Date
Dec 31, 2022
Form Description
Annual report which provides a comprehensive overview of the company for the past year
Filing Group
Annual Filings
Company
MeiraGTx
Issuer
MeiraGTx Holdings plc
Filing Formats
View HTML
Download PDF
Download DOC
Download XLS
XBRL
XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.CAL - EX-101.CAL
EX-101.DEF - EX-101.DEF
EX-101.LAB - EX-101.LAB
EX-101.PRE - EX-101.PRE
XML - XBRL INSTANCE DOCUMENT

Investors & Media

  • Overview
  • News Releases
  • Events & Presentations
  • Stock Information
  • Corporate Governance
  • Financial Information
  • Investor Resources

Stockholder Tools

  • Print Page
  • RSS Feeds
  • Email Page
  • Email Alerts
MeiraGTx

© MeiraGTx Limited. All Rights Reserved.

  • Privacy Policy
  • Sitemap
  • Company
  • Our Strategy
  • Research & Development
  • Patients & Families
  • Investors & Media
  • Join Our Team
  • Facebook
  • Twitter
  • LinkedIn